FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pierfrancesco Marconi

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Emanuela Rosati; Rita Sabatini; Isabella Screpanti; Andrea Bartoli; Laura Cavalli; Filomena De Falco; Beatrice Del Papa; Mauro Di Ianni; Franca Falzetti; Katia Fettucciari; Pierfrancesco Marconi
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation.
Beatrice Del Papa; Stefano Baldoni; Chiara Balucani; Debora Cecchini; Franca Falzetti; Katia Fettucciari; Pierfrancesco Marconi; Massimo F Martelli; Emanuela Rosati; Paolo Sportoletti; Mauro Di Ianni
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction.
Paolo Sportoletti; Stefano Baldoni; Laura Cavalli; Beatrice Del Papa; Elisabetta Bonifacio; Raffaella Ciurnelli; Alain Sylvin Bell; Ambra Di Tommaso; Emanuela Rosati; Barbara Crescenzi; Cristina Mecucci; Isabella Screpanti; Pierfrancesco Marconi; Massimo F Martelli; Mauro Di Ianni; Franca Falzetti
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pierfrancesco Marconi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Emanuela Rosati; Rita Sabatini; Isabella Screpanti; Andrea Bartoli; Laura Cavalli; Filomena De Falco; Beatrice Del Papa; Mauro Di Ianni; Franca Falzetti; Katia Fettucciari; Pierfrancesco Marconi
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation.
International journal of cancer. Journal international du cancer 2013;132(8):1940-53.
2013: Beatrice Del Papa; Stefano Baldoni; Chiara Balucani; Debora Cecchini; Franca Falzetti; Katia Fettucciari; Pierfrancesco Marconi; Massimo F Martelli; Emanuela Rosati; Paolo Sportoletti; Mauro Di Ianni
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction.
European journal of immunology 2013;43(1):182-7.
2010: Paolo Sportoletti; Stefano Baldoni; Laura Cavalli; Beatrice Del Papa; Elisabetta Bonifacio; Raffaella Ciurnelli; Alain Sylvin Bell; Ambra Di Tommaso; Emanuela Rosati; Barbara Crescenzi; Cristina Mecucci; Isabella Screpanti; Pierfrancesco Marconi; Massimo F Martelli; Mauro Di Ianni; Franca Falzetti
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL.
British journal of haematology 2010;151(4):404-6.
2010: Emanuela Rosati; Rita Sabatini; Giuliana Rampino; Filomena De Falco; Mauro Di Ianni; Franca Falzetti; Katia Fettucciari; Andrea Bartoli; Isabella Screpanti; Pierfrancesco Marconi
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL.
Blood 2010;116(15):2713-23.
2010: Federica Susta; Davide Chiasserini; Katia Fettucciari; Pier-Luigi Orvietani; Flavia Quotadamo; Rosina Noce; Andrea Bartoli; Pierfrancesco Marconi; Lanfranco Corazzi; Luciano Binaglia
Protein expression changes induced in murine peritoneal macrophages by Group B Streptococcus.
Proteomics 2010;10(11):2099-112.
2009: Beatrice Paradiso; Pierfrancesco Marconi; Silvia Zucchini; Elena Berto; Anna Binaschi; Aleksandra Bozac; Andrea Buzzi; Manuela Mazzuferi; Eros Magri; Graciela Navarro Mora; Donata Rodi; Tao Su; Ilaria Volpi; Lara Zanetti; Andrea Marzola; Roberto Manservigi; Paolo F Fabene; Michele Simonato
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(17):7191-6.
2009: Emanuela Rosati; Rita Sabatini; Giuliana Rampino; Antonio Tabilio; Mauro Di Ianni; Katia Fettucciari; Andrea Bartoli; Stefano Coaccioli; Isabella Screpanti; Pierfrancesco Marconi
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells.
Blood 2009;113(4):856-65.
2008: Christiane Dresch; Stephanie L Edelmann; Pierfrancesco Marconi; Thomas Brocker
Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(7):4495-506.
2008: Nancy Luckashenak; Samira Schroeder; Katrin Endt; Darja Schmidt; Karsten Mahnke; Martin F Bachmann; Pierfrancesco Marconi; Cornelia A Deeg; Thomas Brocker
Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo.
Immunity 2008;28(4):521-32.
2008: Pierfrancesco Marconi; Rafaela Argnani; Elena Berto; Alberto L Epstein; Roberto Manservigi
HSV as a vector in vaccine development and gene therapy.
Human vaccines 2008;4(2):91-105.
2008: Enrico Capodicasa; Paola Cornacchione; B Natalini; A Bartoli; Stefano Coaccioli; Pierfrancesco Marconi; Lucia Scaringi
Omeprazole induces apoptosis in normal human polymorphonuclear leucocytes.
International journal of immunopathology and pharmacology 2008;21(1):73-85.
2007: Elena Berto; Aleksandra Bozac; I Volpi; Irene Lanzoni; F Vasquez; N Melara; Roberto Manservigi; Pierfrancesco Marconi
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth.
Cancer gene therapy 2007;14(9):791-801.
2007: Simona Fiorentini; Pierfrancesco Marconi; Manuela Avolio; Elena Marini; Emirena Garrafa; Sonia Caracciolo; Daniele Rossi; Alexandra Bozac; Pablo Daniel Becker; Francesca Gentili; Fabio Facchetti; Carlos A Guzman; Roberto Manservigi; Arnaldo Caruso
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses.
Microbes and infection / Institut Pasteur 2007;9(8):988-96.
2007: Melanie Werner-Klein; Christiane Dresch; Pierfrancesco Marconi; Thomas Brocker
Transcriptional targeting of B cells for induction of peripheral CD8 T cell tolerance.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(12):7738-46.
2007: Emanuela Rosati; Simona Mencarelli; A Magini; Rita Sabatini; Carmelo Tassi; Antonio Orlacchio; Stefano Coaccioli; Antonio Frenguelli; Pierfrancesco Marconi; Carla Emiliani
Enhancement of lysosomal glycohydrolase activity in human primary B lymphocytes during spontaneous apoptosis.
International journal of immunopathology and pharmacology 2007;20(2):279-87.
2007: Roberto Furlan; Alessandra Bergami; Elena Brambilla; Erica Butti; M G De Simoni; M Campagnoli; Pierfrancesco Marconi; Giancarlo Comi; Gianvito Martino
HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.
Gene therapy 2007;14(1):93-8.
2006: Aleksandra Bozac; Elena Berto; Federica Vasquez; Paola Grandi; Antonella Caputo; Roberto Manservigi; Barbara Ensoli; Pierfrancesco Marconi
Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses.
Vaccine 2006;24(49-50):7148-58.
2006: Katia Fettucciari; Ilaria Fetriconi; Roberta Mannucci; Ildo Nicoletti; Andrea Bartoli; Stefano Coaccioli; Pierfrancesco Marconi
Group B Streptococcus induces macrophage apoptosis by calpain activation.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(12):7542-56.
2006: Simona Fiorentini; Pablo Daniel Becker; Elena Marini; Pierfrancesco Marconi; Manuela Avolio; Giorgio Tosti; Claudia Link; Roberto Manservigi; Carlos A Guzman; Arnaldo Caruso
HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens.
Viral immunology 2006;19(2):177-88.
2005: Alberto L Epstein; Pierfrancesco Marconi; Rafaela Argnani; Roberto Manservigi
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy.
Current gene therapy 2005;5(5):445-58.
2005: Elena Berto; Aleksandra Bozac; Pierfrancesco Marconi
Development and application of replication-incompetent HSV-1-based vectors.
Gene therapy 2005;12 Suppl 1():S98-102.
2005: Henning Lauterbach; Christine Ried; Alberto L Epstein; Pierfrancesco Marconi; Thomas Brocker
Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity.
The Journal of general virology 2005;86(Pt 9):2401-10.
2005: Sabata Martino; Pierfrancesco Marconi; Brunella Tancini; Diego Dolcetta; M G Cusella De Angelis; Pia Montanucci; Gianni Bregola; K Sandhoff; Claudio Bordignon; Carla Emiliani; Roberto Manservigi; Antonio Orlacchio
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease.
Human molecular genetics 2005;14(15):2113-23.
2005: Emanuela Rosati; Rita Sabatini; Antonio Tabilio; Mauro Di Ianni; Andrea Bartoli; Pierfrancesco Marconi
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha.
Leukemia research 2005;29(7):829-39.
2005: Pierfrancesco Marconi; Silvia Zucchini; Elena Berto; Aleksandra Bozac; Beatrice Paradiso; Gianni Bregola; C Grassi; I Volpi; Rafaela Argnani; Andrea Marzola; Roberto Manservigi; Michele Simonato
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo.
Gene therapy 2005;12(7):559-69.
2004: Antonio Tabilio; Franca Falzetti; Tiziana Zei; Maria De Ioanni; Elisabetta Bonifacio; Feliciana Battelli; Roberta Iacucci Ostini; Stelvio Ballanti; Michele Cimminiello; Monia Capponi; Carla Silvani; Olivia Minelli; Katia Fettucciari; Pierfrancesco Marconi; Emanuela Rosati; Antonella Santucci; Mauro Di Ianni; Franco Aversa; Massimo F Martelli
Graft engineering for allogeneic haploidentical stem cell transplantation.
Blood cells, molecules & diseases 2004;33(3):274-80.
2004: Lucia Scaringi; Paola Cornacchione; Emira Ayroldi; Lanfranco Corazzi; Enrico Capodicasa; Ruggero Rossi; Pierfrancesco Marconi
Omeprazole induces apoptosis in jurkat cells.
International journal of immunopathology and pharmacology 2004;17(3):331-42.
2004: Rafaela Argnani; Luca Boccafogli; Pierfrancesco Marconi; Roberto Manservigi
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.
Gene therapy 2004;11(13):1087-98.
2004: Emanuela Rosati; Rita Sabatini; Emira Ayroldi; Antonio Tabilio; Andrea Bartoli; Stefano Bruscoli; Costantino Simoncelli; Ruggero Rossi; Pierfrancesco Marconi
Apoptosis of human primary B lymphocytes is inhibited by N-acetyl-L-cysteine.
Journal of leukocyte biology 2004;76(1):152-61.
2004: Henning Lauterbach; Kristen M Kerksiek; Dirk H Busch; Elena Berto; Aleksandra Bozac; Penelope Mavromara; Roberto Manservigi; Alberto L Epstein; Pierfrancesco Marconi; Thomas Brocker
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1.
Journal of virology 2004;78(8):4020-8.
2004: Ravera Raffaella; Daniela Gioia; Marco De Andrea; Paola Cappello; Mirella Giovarelli; Pierfrancesco Marconi; Roberto Manservigi; Marisa Gariglio; Santo Landolfo
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells.
Experimental cell research 2004;293(2):331-45.
2003: Andrea Bartoli; Katia Fettucciari; Ilaria Fetriconi; Emanuela Rosati; Mauro Di Ianni; Antonio Tabilio; Domenico Vittorio Delfino; Ruggero Rossi; Pierfrancesco Marconi
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells.
Pharmacological research : the official journal of the Italian Pharmacological Society 2003;48(1):111-8.
2003: Katia Fettucciari; Ilaria Fetriconi; Andrea Bartoli; Ruggero Rossi; Pierfrancesco Marconi
Involvement of mitogen-activated protein kinases in Group B Streptococcus-induced macrophage apoptosis.
Pharmacological research : the official journal of the Italian Pharmacological Society 2003;47(4):355-62.
2003: Roberto Furlan; Stefano Pluchino; Pierfrancesco Marconi; Gianvito Martino
Cytokine gene delivery into the central nervous system using intrathecally injected nonreplicative viral vectors.
Methods in molecular biology (Clifton, N.J.) 2003;215():279-89.
2002: Elisabetta Chiaradia; Alberto Gaiti; Lucia Scaringi; Paola Cornacchione; Pierfrancesco Marconi; Luca Avellini
Antioxidant systems and lymphocyte proliferation in the horse, sheep and dog.
Veterinary research 2002;33(6):661-8.
2002: William F Goins; Pierfrancesco Marconi; David M Krisky; Darren Wolfe; Joseph C Glorioso; Ramesh Ramakrishnan; David J Fink
Construction of replication-defective herpes simplex virus vectors.
Current protocols in human genetics / editorial board, Jonathan L. Haines ... [et al.] 2002;Chapter 12():Unit 12.11.
2002: Sandra Buratta; Katia Fettucciari; Raffaela Mambrini; Ilaria Fetriconi; Pierfrancesco Marconi; Rita Mozzi
Group B streptococcus (GBS) modifies macrophage phosphatidylserine metabolism during induction of apoptosis.
FEBS letters 2002;520(1-3):68-72.
2001: Ruffini Francesca; Roberto Furlan; PL Poliani; Elena Brambilla; Pierfrancesco Marconi; Alessandra Bergami; G Desina; Joseph C Glorioso; Giancarlo Comi; Gianvito Martino
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice.
Gene therapy 2001;8(16):1207-13.
2001: Roberto Furlan; Elena Brambilla; Ruffini Francesca; PL Poliani; Alessandra Bergami; Pierfrancesco Marconi; Diego Franciotta; Giuseppe Penna; Giancarlo Comi; Luciano Adorini; Gianvito Martino
Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(3):1821-9.
2001: PL Poliani; Herbert P M Brok; Roberto Furlan; Ruffini Francesca; Alessandra Bergami; G Desina; Pierfrancesco Marconi; Marco Rovaris; Antonio Uccelli; Joseph C Glorioso; Giuseppe Penna; Luciano Adorini; Giancarlo Comi; B 't Hart; Gianvito Martino
Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis.
Human gene therapy 2001;12(8):905-20.
2001: Roberto Furlan; PL Poliani; Pierfrancesco Marconi; Alessandra Bergami; Ruffini Francesca; Luciano Adorini; Joseph C Glorioso; Giancarlo Comi; Gianvito Martino
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.
Gene therapy 2001;8(1):13-9.
2000: Katia Fettucciari; Emanuela Rosati; Lucia Scaringi; Paola Cornacchione; Graziella Migliorati; Rita Sabatini; Ilaria Fetriconi; Ruggero Rossi; Pierfrancesco Marconi
Group B Streptococcus induces apoptosis in macrophages.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(7):3923-33.
2000: Shusuke Moriuchi; David M Krisky; Pierfrancesco Marconi; Masakazu Tamura; K Shimizu; Toshiki Yoshimine; Justus B Cohen; Joseph C Glorioso
HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
Gene therapy 2000;7(17):1483-90.
2000: Gianvito Martino; PL Poliani; Roberto Furlan; Pierfrancesco Marconi; Joseph C Glorioso; Luciano Adorini; G Comi
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach.
Journal of neuroimmunology 2000;107(2):184-90.
2000: Gianvito Martino; PL Poliani; Pierfrancesco Marconi; Giancarlo Comi; Roberto Furlan
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors.
Gene therapy 2000;7(13):1087-93.
2000: Michele Simonato; Roberto Manservigi; Pierfrancesco Marconi; J Glorioso
Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors.
Trends in neurosciences 2000;23(5):183-90.
2000: Paola Cornacchione; Lucia Scaringi; Enrico Capodicasa; Katia Fettucciari; Emanuela Rosati; Rita Sabatini; Claudia Benedetti; Pierfrancesco Marconi; Ruggero Rossi; A Del Favero
In vitro effects of meropenem and imipenem/cilastatin on some functions of human natural effector cells.
Chemotherapy 2000;46(2):135-42.
2000: Mauro Di Ianni; Adelmo Terenzi; Sabrina Di Florio; Gigliola Venditti; Roberta Benedetti; Antonella Santucci; Andrea Bartoli; Katia Fettucciari; Pierfrancesco Marconi; Ruggero Rossi; Massimo F Martelli; Antonio Tabilio
In vivo demethylation of a MoMuLV retroviral vector expressing the herpes simplex thymidine kinase suicide gene by 5' azacytidine.
Stem cells (Dayton, Ohio) 2000;18(6):415-21.
2000: Pierfrancesco Marconi; Masakazu Tamura; Shusuke Moriuchi; David M Krisky; Ajay Niranjan; William F Goins; Justus B Cohen; Joseph C Glorioso
Connexin 43-enhanced suicide gene therapy using herpesviral vectors.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;1(1):71-81.
2000: Jesús Gómez-Navarro; Juan L Contreras; Waleed O Arafat; Xiao Ling Jiang; David M Krisky; Thomas J Oligino; Pierfrancesco Marconi; B Hubbard; Joseph C Glorioso; David T Curiel; Judith M Thomas
Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model.
Gene therapy 2000;7(1):43-52.
1999: Darren Wolfe; William F Goins; M Yamada; Shusuke Moriuchi; David M Krisky; Thomas J Oligino; Pierfrancesco Marconi; David J Fink; Joseph C Glorioso
Engineering herpes simplex virus vectors for CNS applications.
Experimental neurology 1999;159(1):34-46.
1999: Michele Simonato; Pierfrancesco Marconi; J Glorioso; Roberto Manservigi
Molecular analysis of behavior by gene transfer into neurons with herpes simplex vectors.
Brain research 1999;835(1):37-45.
1999: Pierfrancesco Marconi; Michele Simonato; Silvia Zucchini; Gianni Bregola; Rafaela Argnani; David M Krisky; Joseph C Glorioso; Roberto Manservigi
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo.
Gene therapy 1999;6(5):904-12.
1998: Shusuke Moriuchi; Thomas J Oligino; David M Krisky; Pierfrancesco Marconi; David J Fink; J Cohen; Joseph C Glorioso
Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.
Cancer research 1998;58(24):5731-7.
1998: David M Krisky; Darren Wolfe; William F Goins; Pierfrancesco Marconi; R Ramakrishnan; Marina Mata; RJ Rouse; David J Fink; Joseph C Glorioso
Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons.
Gene therapy 1998;5(12):1593-603.
1998: David M Krisky; Pierfrancesco Marconi; Thomas J Oligino; RJ Rouse; David J Fink; Justus B Cohen; simon simon watkins; Joseph C Glorioso
Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications.
Gene therapy 1998;5(11):1517-30.
1998: Minghui Wang; Claudine Rancourt; Jesus Gomez-Navarro; David M Krisky; Pierfrancesco Marconi; Thomas J Oligino; Ronald D Alvarez; Gene P Siegal; Joseph C Glorioso; David T Curiel
High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector.
Gynecologic oncology 1998;71(2):278-87.
1998: J C van Deutekom; SS Floyd; D K Booth; Thomas J Oligino; David M Krisky; Pierfrancesco Marconi; JC Glorioso; Johnny Huard
Implications of maturation for viral gene delivery to skeletal muscle.
Neuromuscular disorders : NMD 1998;8(3-4):135-48.
1998: Emanuela Rosati; Katia Fettucciari; Lucia Scaringi; Paola Cornacchione; Rita Sabatini; L Mezzasoma; Ruggero Rossi; Pierfrancesco Marconi
Cytokine response to group B streptococcus infection in mice.
Scandinavian journal of immunology 1998;47(4):314-23.
1998: Nelly Kuklin; M Daheshia; Pierfrancesco Marconi; David M Krisky; RJ Rouse; Joseph C Glorioso; E Manican; Barry T Rouse
Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines.
Virology 1998;240(2):245-53.
1998: Paola Cornacchione; Lucia Scaringi; Katia Fettucciari; Emanuela Rosati; Rita Sabatini; Graziella Orefici; Christina von Hunolstein; A Modesti; Anna Modica; F Minelli; Pierfrancesco Marconi
Group B streptococci persist inside macrophages.
Immunology 1998;93(1):86-95.
1997: C Rossi; Pier Giorgio Balboni; Monica Betti; Pierfrancesco Marconi; R Bozzini; Maria Pia Grossi; Giuseppe Barbanti-Brodano; Antonella Caputo
Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients.
Gene therapy 1997;4(11):1261-9.
1997: David M Krisky; Pierfrancesco Marconi; Thomas J Oligino; RJ Rouse; David J Fink; Joseph C Glorioso
Rapid method for construction of recombinant HSV gene transfer vectors.
Gene therapy 1997;4(10):1120-5.
1997: Johnny Huard; David M Krisky; Thomas J Oligino; Pierfrancesco Marconi; Charles S Day; simon simon watkins; JC Glorioso
Gene transfer to muscle using herpes simplex virus-based vectors.
Neuromuscular disorders : NMD 1997;7(5):299-313.
1997: William F Goins; David M Krisky; Pierfrancesco Marconi; Thomas J Oligino; R Ramakrishnan; PL Poliani; David J Fink; Joseph C Glorioso
Herpes simplex virus vectors for gene transfer to the nervous system.
Journal of neurovirology 1997;3 Suppl 1():S80-8.
1997: Joseph C Glorioso; William F Goins; Martin C Schmidt; Thomas J Oligino; David M Krisky; Pierfrancesco Marconi; James Cavalcoli; R Ramakrishnan; PL Poliani; David J Fink
Engineering herpes simplex virus vectors for human gene therapy.
Advances in pharmacology (San Diego, Calif.) 1997;40():103-36.
1996: Pierfrancesco Marconi; David M Krisky; Thomas J Oligino; PL Poliani; R Ramakrishnan; William F Goins; David J Fink; Joseph C Glorioso
Replication-defective herpes simplex virus vectors for gene transfer in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(21):11319-20.
1996: Thomas J Oligino; PL Poliani; Pierfrancesco Marconi; M A Bender; Martin C Schmidt; David J Fink; Joseph C Glorioso
In vivo transgene activation from an HSV-based gene therapy vector by GAL4:vp16.
Gene therapy 1996;3(10):892-9.
1996: Emanuela Rosati; Lucia Scaringi; Paola Cornacchione; Katia Fettucciari; Rita Sabatini; L Mezzasoma; C Benedetti; S Cianetti; R Rossi; Pierfrancesco Marconi
Activation of cytokine genes during primary and anamnestic immune response to inactivated c. albicans.
Immunology 1996;89(1):142-51.
1996: Lucia Scaringi; Paola Cornacchione; Katia Fettucciari; Emanuela Rosati; R Rossi; Pierfrancesco Marconi; Enrico Capodicasa
Activity inhibition of cytolytic lymphocytes by omeprazole.
Scandinavian journal of immunology 1996;44(3):204-14.
1996: Antonella Caputo; Maria Pia Grossi; R Bozzini; C Rossi; Monica Betti; Pierfrancesco Marconi; Giuseppe Barbanti-Brodano; Pier Giorgio Balboni
Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region.
Gene therapy 1996;3(3):235-45.
1995: Roberto Biondi; Enrico Capodicasa; Carmelo Tassi; L Mezzasoma; C Benedetti; M Valiani; Pierfrancesco Marconi; R Rossi
Cardiovascular and organ responses and adaptation responses to hypogravity in an experimental animal model.
Acta astronautica 1995;37():373-7.
1995: Lucia Scaringi; Emanuela Rosati; Paola Cornacchione; Katia Fettucciari; Rita Sabatini; Roberto Biondi; L Mezzasoma; M Valiani; P D'Errico; Pierfrancesco Marconi
Local and systemic immune response to inactivated Candida albicans in mice.
Natural immunity 1995;14(5-6):234-49.
1995: Emanuela Rosati; Lucia Scaringi; Paola Cornacchione; Katia Fettucciari; Rita Sabatini; R Rossi; Pierfrancesco Marconi
Cytokine response to inactivated Candida albicans in mice.
Cellular immunology 1995;162(2):256-64.
1995: David J Fink; R Ramakrishnan; Pierfrancesco Marconi; William F Goins; Thomas C Holland; Joseph C Glorioso
Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system.
Clinical neuroscience (New York, N.Y.) 1995;3(5):284-91.
1994: Lucia Scaringi; Luciana Tissi; Paola Cornacchione; Emanuela Rosati; C Campanelli; Christina von Hunolstein; Graziella Orefici; R Rossi; Pierfrancesco Marconi
Antibody-independent protection in mice against type Ia group B streptococcus lethal infection.
FEMS immunology and medical microbiology 1994;9(2):151-62.
1994: Lucia Scaringi; Paola Cornacchione; Emanuela Rosati; Katia Fettucciari; R Rossi; Pierfrancesco Marconi
Induction and persistence in vivo of NK/LAK activity by a mannoprotein component of Candida albicans cell wall.
Cellular immunology 1994;155(2):265-82.
1993: Pier Giorgio Balboni; R Bozzini; Silvia Zucchini; Pierfrancesco Marconi; Maria Pia Grossi; Antonella Caputo; Roberto Manservigi; Giuseppe Barbanti-Brodano
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant.
Journal of medical virology 1993;41(4):289-95.
1993: L Mezzasoma; Roberto Biondi; C Benedetti; C Floridi; R Ciurnelli; F Falcinelli; M Onorato; Lucia Scaringi; Pierfrancesco Marconi; R Rossi
In vitro production of leukemia inhibitory factor (LIF) by Hep G2 hepatoblastoma cells.
Journal of biological regulators and homeostatic agents 1993;7(4):126-32.
1993: Maria Pia Grossi; Antonella Caputo; Silvia Zucchini; R Bozzini; Pierfrancesco Marconi; Roberto Manservigi; Giuseppe Barbanti-Brodano; Pier Giorgio Balboni
Molecular approaches to inhibit HIV-1 tat expression and functions.
The Year in immunology 1993;7():199-204.
1992: Lucia Scaringi; Emanuela Rosati; Paola Cornacchione; R Rossi; Pierfrancesco Marconi
In vivo modulation of lymphokine-activated killer cell activity by cell wall components of Candida albicans.
Cellular immunology 1992;139(2):438-54.
1991: Lucia Scaringi; Elisabetta Blasi; Emanuela Rosati; Pierfrancesco Marconi; Francesco Bistoni
Fungicidal activity of Candida albicans-induced murine lymphokine-activated killer cells against C. albicans hyphae in vitro.
Journal of general microbiology 1991;137(12):2851-6.
1991: Enrico Capodicasa; Lucia Scaringi; Emanuela Rosati; F De Bellis; G Sbaraglia; Pierfrancesco Marconi; Albano Del Favero
In-vitro effects of teicoplanin, teicoplanin derivative MDL 62211 and vancomycin on human polymorphonuclear cell function.
The Journal of antimicrobial chemotherapy 1991;27(5):619-26.
1990: Luciana Tissi; Pierfrancesco Marconi; Paolo Mosci; L Merletti; Paola Cornacchione; Emanuela Rosati; Simona Recchia; Christina von Hunolstein; Graziella Orefici
Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritis.
Infection and immunity 1990;58(9):3093-100.
1990: Lucia Scaringi; Paola Cornacchione; Emanuela Rosati; M Boccanera; Antonio Cassone; Francesco Bistoni; Pierfrancesco Marconi
Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans.
Cellular immunology 1990;129(2):271-87.
1990: Elisabetta Blasi; Lucia Pitzurra; A M Burhan Fuad; Pierfrancesco Marconi; Francesco Bistoni
Gamma interferon-induced specific binding of tetanus toxin on the GG2EE macrophage cell line.
Scandinavian journal of immunology 1990;32(3):289-92.
1989: Lucia Pitzurra; Pierfrancesco Marconi; Francesco Bistoni; Elisabetta Blasi
Selective inhibition of cytokine-induced lysozyme activity by tetanus toxin in the GG2EE macrophage cell line.
Infection and immunity 1989;57(8):2452-6.
1989: Lucia Scaringi; M Rosati; Francesco Bistoni; Antonio Cassone; Pierfrancesco Marconi
Lymphokine-activated killer (LAK)-like cells induced in mice after repeated intraperitoneal injections of inactivated Candida albicans.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):446-8.
1989: Rosanna Mazzolla; Roberta Barluzzi; M Marangi; Anna Vecchiarelli; R Rossi; Pierfrancesco Marconi
D-mannose in serum as indicator of systemic candidiasis in an experimental model.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):245-7.
1989: G Verducci; Stefano Perito; R Rossi; Francesco Bistoni; Pierfrancesco Marconi
Identification of a trypanocidal factor in normal human sera.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):46-8.
1989: Luciana Tissi; Paolo Mosci; Paola Cornacchione; Christina von Hunolstein; Simona Recchia; Graziella Orefici; P Alberti; Francesco Bistoni; Pierfrancesco Marconi
A murine model of systemic infection with serotype IV group B streptococcus.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):21-3.
1989: G Verducci; Stefano Perito; R Rossi; E Mannarino; Francesco Bistoni; Pierfrancesco Marconi
Identification of a trypanocidal factor against Trypanosoma equiperdum in normal human serum.
Parasitology 1989;98 Pt 3():401-7.
1988: Lucia Scaringi; Pierfrancesco Marconi; M Boccanera; Luciana Tissi; Francesco Bistoni; Antonio Cassone
Cell wall components of Candida albicans as immunomodulators: induction of natural killer and macrophage-mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions.
Journal of general microbiology 1988;134(5):1265-74.
1988: L Bastianini; T Sposini; A Bartoli; Pierfrancesco Marconi
Comparative in vitro activity of imipenem against gram-positive and gram-negative aerobic bacteria from clinical isolates.
Microbiologica 1988;11(2):137-42.
1988: Francesco Bistoni; G Verducci; Stefano Perito; Anna Vecchiarelli; Paolo Puccetti; Pierfrancesco Marconi; Antonio Cassone
Immunomodulation by a low-virulence, agerminative variant of Candida albicans. Further evidence for macrophage activation as one of the effector mechanisms of nonspecific anti-infectious protection.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1988;26(5):285-99.
1985: Pierfrancesco Marconi; Lucia Scaringi; Luciana Tissi; M Boccanera; Francesco Bistoni; E Bonmassar; Antonio Cassone
Induction of natural killer cell activity by inactivated Candida albicans in mice.
Infection and immunity 1985;50(1):297-303.
1985: Francesco Bistoni; Pierfrancesco Marconi; Stefano Perito; L Bastianini; R Antenucci; M Pitzurra
Turkey red blood cell passive haemagglutination assay as guideline for specific prevention of tetanus in injured persons.
Bulletin of the World Health Organization 1985;63(5):905-14.
1984: Luciana Tissi; Lucia Scaringi; Antonio Cassone; P D'Errico; Pierfrancesco Marconi
[Immunostimulation with inactivated Candida albicans and chemotherapy in murine lymphoma].
Giornale italiano di chemioterapia 1984;31(1-2):91-100.
1984: Lucia Scaringi; Luciana Tissi; Antonio Cassone; M Boccanera; Pierfrancesco Marconi
[Immune response to a histocompatible murine lymphoma. Synergism with chemotherapy].
Giornale italiano di chemioterapia 1984;31(1-2):81-90.
1984: Pierfrancesco Marconi; Lucia Scaringi; Luciana Tissi; Paolo Puccetti; Antonio Cassone
Combined effects of chemotherapy and host antitumor response in a murine histocompatible lymphoma model.
International journal of immunopharmacology 1984;6(3):217-22.
1983: M Pitzurra; A B Calderazzo; Pierfrancesco Marconi; L Bastianini; Lucia Pitzurra; E Biasini
[Importance of monitoring specific antibody serum titers for optimal passive immune protection in the tetanic patient].
Minerva anestesiologica 1983;49(10):597-604.
1983: Pierfrancesco Marconi; Antonio Cassone; M Baccarini; Luciana Tissi; E Garaci; E Bonmassar; L Frati; Francesco Bistoni
Relationships among tumor load, route of tumor inoculation, and response to immunochemotherapy in a murine lymphoma model.
Journal of the National Cancer Institute 1983;71(2):299-307.
1983: Antonio Cassone; Lucia Scaringi; C D Pesce; F Titti; Francesco Bistoni; Pierfrancesco Marconi; G B Rossi
Suppression of Friend leukemia cell-induced tumours by cellular preparations of Candida albicans.
Microbiologica 1983;6(3):207-20.
1983: Lucia Pitzurra; Francesco Bistoni; M Pitzurra; L Bastianini; Stefano Perito; Anna Vecchiarelli; Pierfrancesco Marconi
Comparison of passive hemagglutination with Turkey erythrocyte assay, enzyme-linked immunosorbent assay, and counterimmunoelectrophoresis assay for serological evaluation of tetanus immunity.
Journal of clinical microbiology 1983;17(3):432-5.
1983: Francesco Bistoni; M Pitzurra; Pierfrancesco Marconi
[The use of passive hemagglutination with turkey erythrocytes for the effective prevention of tetanus in wounded patients].
Bollettino dell'Istituto sieroterapico milanese 1983;62(6):575-9.
1983: Pierfrancesco Marconi; M Pitzurra; Francesco Bistoni
Determination of immunity against tetanus infection by passive haemagglutination assay.
Bollettino dell'Istituto sieroterapico milanese 1983;62(6):567-74.
1983: M Pitzurra; Francesco Bistoni; Lucia Pitzurra; Pierfrancesco Marconi
Use of turkey red blood cells in the passive haemagglutination test for studying tetanus immunity.
Bulletin of the World Health Organization 1983;61(2):331-8.
1982: Pierfrancesco Marconi; M Pitzurra; Anna Vecchiarelli; Lucia Pitzurra; Francesco Bistoni
Resistance induced by concanavalin A and phytohaemagglutinin P against tetanus toxin in mice.
Annales d'immunologie 1982;133D(1):15-27.
1982: Antonio Cassone; Francesco Bistoni; E Cenci; C D Pesce; Luciana Tissi; Pierfrancesco Marconi
Immunopotentiation of anticancer chemotherapy by Candida albicans, other yeasts and insoluble glucan in an experimental lymphoma model.
Sabouraudia 1982;20(2):115-25.
1982: Pierfrancesco Marconi; Antonio Cassone; Luciana Tissi; M Baccarini; Paolo Puccetti; E Garaci; E Bonmassar; Francesco Bistoni
Cellular mechanisms underlying the adjuvant activity of Candida albicans in a mouse lymphoma model.
International journal of cancer. Journal international du cancer 1982;29(4):483-8.
1982: C Delfina Pesce; M Boccanera; Pierfrancesco Marconi; Francesco Bistoni; E Cenci; Luciana Tissi; Antonio Cassone
[Further study of immunopotentiation in experimental antiblastic therapy by inactivated yeasts and glucan].
Annali dell'Istituto superiore di sanità 1982;18(3):509-12.
1980: Pierfrancesco Marconi; Francesco Bistoni; L Bastianini; Luciana Tissi; G Sbaraglia; M Pitzurra
Protection test and early antibody response to tetanus immunization.
Bollettino dell'Istituto sieroterapico milanese 1980;59(4):374-9.